<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Health Сare of the Russian Federation</journal-id><journal-title-group><journal-title xml:lang="en">Health Сare of the Russian Federation</journal-title><trans-title-group xml:lang="ru"><trans-title>Здравоохранение Российской Федерации</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0044-197X</issn><issn publication-format="electronic">2412-0723</issn><publisher><publisher-name xml:lang="en">Federal Scientific Center for Hygiene F.F.Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">637574</article-id><article-id pub-id-type="doi">10.18821/0044-197Х-2018-62-3-116-120</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>HEALTH CARE ORGANIZATION</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE SOCIAL FINANCIAL LOAD OF OPPORTUNISTIC SCREENING OF BREAST CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>СОЦИАЛЬНАЯ ФИНАНСОВАЯ НАГРУЗКА ОППОРТУНИСТИЧЕСКОГО СКРИНИНГА РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Apanasevich</surname><given-names>V. I.</given-names></name><name xml:lang="ru"><surname>Апанасевич</surname><given-names>В. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>oncolog222@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiku</surname><given-names>P. F.</given-names></name><name xml:lang="ru"><surname>Кику</surname><given-names>П. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Faizinger</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Файзингер</surname><given-names>А. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zagrudinova</surname><given-names>O. M.</given-names></name><name xml:lang="ru"><surname>Загрудинова</surname><given-names>О. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sedykh</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Седых</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yudin</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Юдин</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Moreva</surname><given-names>V. G.</given-names></name><name xml:lang="ru"><surname>Морева</surname><given-names>В. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sukhova</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Сухова</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff5"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The Pacific State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The Primorskiy Regional Oncologic Dispensary</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Приморский краевой онкологический диспансер»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">The Far East Federal University, the School of Biomedicine</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Дальневосточный федеральный университет»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">The Primorskiy Krai hospital №1</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Приморская краевая больница №1»</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">The F.F. Erisman Federal Research Center of Hygiene</institution></aff><aff><institution xml:lang="ru">ФБУН «Федеральный научный центр гигиены им. Ф.Ф. Эрисмана» Роспотребнадзора</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-06-16" publication-format="electronic"><day>16</day><month>06</month><year>2018</year></pub-date><volume>62</volume><issue>3</issue><issue-title xml:lang="ru"/><fpage>116</fpage><lpage>120</lpage><history><date date-type="received" iso-8601-date="2024-10-25"><day>25</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Apanasevich V.I., Kiku P.F., Faizinger A.G., Zagrudinova O.M., Sedykh A.A., Yudin S.V., Moreva V.G., Sukhova A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Апанасевич В.И., Кику П.Ф., Файзингер А.Г., Загрудинова О.М., Седых А.А., Юдин С.В., Морева В.Г., Сухова А.В.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Apanasevich V.I., Kiku P.F., Faizinger A.G., Zagrudinova O.M., Sedykh A.A., Yudin S.V., Moreva V.G., Sukhova A.V.</copyright-holder><copyright-holder xml:lang="ru">Апанасевич В.И., Кику П.Ф., Файзингер А.Г., Загрудинова О.М., Седых А.А., Юдин С.В., Морева В.Г., Сухова А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/0044-197X/article/view/637574">https://journals.eco-vector.com/0044-197X/article/view/637574</self-uri><abstract xml:lang="en"><p>The study was carried out concerning complex evaluation of financial load of opportunistic screening of breast cancer. The data of established cases of breast cancer and stages of disease are taken from collections "The state of oncologic care in Russia" 2014, 2015 and 2016. The financial expenses for implementation of analog mammography, sonography and physician's examination are taken from "The territorial tariff agreement 2014". The evaluation of X-ray finds was implemented using categories BI-RADS (Breast Imaging Reporting and Data System) proposed by the American College of Radiology. During 2014, in the Primorskiy Krai 40,825 of diagnostic and 50,824 cases of preventive mammography were implemented. In 2015 43,196 diagnostic and 58,567 preventive examinations and in 2016 47,359 diagnostic and 53 973 preventive examinations were implemented correspondingly. According the Foundation of mandatory medical insurance, the price of analog mammography made up to 292 rubles. The social financial load of diagnostic of a single case of breast cancer at stage T1 made up to 96,367 rubles in 2014, 90,966 rubles in 2015 and 73,303 rubles in 2016 correspondingly. The analysis of detection of breast cancer at early stage T1 and financial costs of early diagnostic demonstrated a distinct trend of decreasing of financial load at diagnostic of a single case of breast cancer of T1 during 2014-2016 at the expense of amelioration of quality of description of picture and training of radiologists. The model was proposed to form groups of higher risk with subsequent detailed examination and implementation of opportunistic screening in the group of common level of risk of development of breast cancer as a most perspective and less unprofitable one.</p></abstract><trans-abstract xml:lang="ru"><p>Проведено исследование по комплексной оценке социальной финансовой нагрузки оппортунистического скрининга рака молочной железы (РМЖ). Данные о выявленных случаях РМЖ и стадии заболевания взяты из сборников «Состояние онкологической помощи населению России…» за 2014, 2015 и 2016 годы. Финансовые затраты на проведение аналоговой маммографии, сонографии и осмотр врача взяты из «Территориального тарифного соглашения на 2014 год». Оценка рентгенологических находок была выполнена с использованием категорий BI-RADS (Breast Imaging Reporting and Data System), предложенных American College of Radiology. За 2014 г. в Приморском крае было выполнено 40 825 диагностических и 50 824 профилактических маммографий. В 2015 г. было выполнено 43 196 диагностических и 58 567 профилактических исследований, а в 2016 г. - 47 359 и 53 973 соответственно. Стоимость аналоговой маммографии на 2014 г. по данным Фонда обязательного медицинского страхования составляла 292 руб. Социальная финансовая нагрузка диагностики одного случая РМЖ в стадии Т1 составляла 96 367 руб. в 2014 г., 90 966 руб. в 2015 г. и 73 303 руб. в 2016 г. На основании анализа выявляемости РМЖ в ранней стадии Т1 и финансовых затрат на раннюю диагностику показана чёткая тенденция к снижению финансовой нагрузки при диагностике одного случая РМЖ в Т1 в период с 2014 по 2016 г. за счёт улучшения качества описания снимков, обучения врачей рентгенологов. Предложена модель формирования групп повышенного риска с их последующим детальным обследованием и проведения оппортунистического скрининга в группе с обычным уровнем риска развития РМЖ как наиболее перспективная и менее затратная на современном этапе.</p></trans-abstract><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>opportunistic screening</kwd><kwd>mammography</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>оппортунистический скрининг</kwd><kwd>маммография</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2016 году. М.; 2017.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Mariotto A., Etzioni R., Hurlbert M., Penberthy L., Mayer M. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol. Biomarkers Prev. 2017; 26(6): 809-15.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Health Quality Ontario. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment. Ont. Health. Technol. Assess Ser. 2016; 16(15): 1-71.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wadasadawala T., Kannan S., Gudi S., Rishi A., Budrukkar A., Parmar V., et al. Predicting loco-regional recurrence risk in T1,T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram. Indian J. Cancer. 2017; 54(1): 352-7.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gray E., Donten A., Karssemeijer N., van Gils C., Evans D.G., Astley S., et al. Value Health. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis. Value Health. 2017; 20(8): 1100-9.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Комарова Л.Е. Скрининговая маммография рака молочной железы. За и против? Сибирский онкологический журнал. 2008; (Прил. 2): 2-14.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Колядина И.В., Поддубная И.В., Комов Д.В. Скрининг рака молочной железы: мировой опыт и перспективы. Российский онкологический журнал. 2015; 20(1): 42-6.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Szynglarewicz B., Matkowski R. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014. Adv. Clin. Exp. Med. 2017; 26(2): 259-62.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2014 году. М.; 2015.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2015 году. М.; 2016.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Территориальное тарифное соглашение на 2014 год. Available at: http://www.omspk.ru/upload/iblock/a75/dopcogl%20N17_tts_2014_ot_13.02.15.doc</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Мордвинов Ю.П., Апанасевич В.И., Болтаев Ю.Ю. Возможности предоперационной диагностики склерозирующего аденоза молочной железы. Тихоокеанский медицинский журнал. 2017; (1): 58-61.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Приказ ДЗАПК №129-0 «О проведении скрининговых мероприятий по раннему выявлению онкологических заболеваний» от 02.03.2015г. Available at: http://docs.cntd.ru/document/428540802</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hanley J.A., Hannigan A., O'Brien K.M. Mortality reductions due to mammography screening: Contemporary population-based data. PLoS One. 2017; 12(12): e0188947.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Kuhl C., Weigel S., Schrading S., Arand B., Bieling H., Konig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J. Clin. Oncol. 2010; 28(9): 1450-7.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Berg W.A., Zhang Z., Lehrer D., Jong R.A., Pisano E.D., Barr R.G. et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012; 307(13): 1394-404.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wanders J.O., Holland K., Veldhuis W.B., Mann R.M., Pijnappel R.M., Peeters P.H. et al. Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res. Treat. 2017; 162(1): 95-103.</mixed-citation></ref></ref-list></back></article>
